The weaver gene continues to target late-generated dopaminergic neurons in midbrain areas at P90

Developmental Brain Research

Volumn 122, Issue 2, 2000, Pages 173-181

  Martí, Joaquín ^a,c   Wills, Katherine V ^a   Ghetti, Bernardino ^b   Bayer, Shirley A ^a  

^a INDIANA UNIVERSITY   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

3H Thymidine autoradiography; Interfascicular nucleus; Retrorubral field; Substantia nigra pars compacta; Tyrosine hydroxylase immunohistochemistry; Ventral tegmental area; Weaver mutant mouse

Indexed keywords

THYMIDINE; TRITIUM; TYROSINE 3 MONOOXYGENASE;

ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; FEMALE; GENE; IMMUNOHISTOCHEMISTRY; MALE; MESENCEPHALON; MOUSE; NERVE CELL DIFFERENTIATION; NONHUMAN; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; SUBSTANTIA NIGRA; VENTRAL TEGMENTUM;

AGING; ANIMALS; ANIMALS, NEWBORN; CELL COUNT; DOPAMINE; MESENCEPHALON; MICE; MICE, NEUROLOGIC MUTANTS; NEURONS; RED NUCLEUS; SUBSTANTIA NIGRA; TIME FACTORS;

ANIMALIA; PLOCEINAE; TRITIUM;

EID: 0034734295     PISSN: 01653806     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-3806(00)00071-7     Document Type: Article

References (30)

1. Agid Y., Ruberg M., Javoy-Agid F., Hirsch E., Raisman-Vozari R., Vyas S., Faucheux B., Michel P., Kastner A., Blanchard V., Damier P., Villares J., Zhang P. Are dopaminergic neurons selectively vulnerable to parkinson's disease. Narabayashi H., Nagatsu T., Yanagisawa N., Mizuro Y., Advances in Neurology. 1993;148-164 Raven Press, New York.
2. Altman J., Bayer S.A. Development of the brain stem in the rat. V. Thymidine-radiographic study of the time of origin of neurons in the midbrain tegmentum. J. Comp. Neurol. 198:1981;677-716.
3. Bayer S.A. Neurogenesis in the rat neostriatum. Int. J. Devl. Neurosci. 2:1984;163-175.
4. Bayer S.A., Altman J. Directions in neurogenetic gradients and patterns of anatomical connections in the telencephalon. Prog. Neurobiol. 29:1987;57-106.
5. Bayer S.A., Triarhou L.C., Thomas J.D., Ghetti B. Correlated quantitative studies of the neostriatum, nucleus accumbens, substantia nigra, and ventral tegmental area in normal and weaver mutant mice. J. Neurosci. 14:1994;6901-6910.
6. Bayer S.A., Wills K.V., Triarhou L.C., Thomas J.D., Ghetti B. Systematic differences in time of dopaminergic neuron origin between normal mice and homozygous weaver mutants. Exp. Brain Res. 105:1995;200-208.
7. Bayer S.A., Wills K.V., Triarhou L.C., Verina T., Thomas J.D., Ghetti B. Selective vulnerability of late-generated dopaminergic neurons of the substantia nigra in weaver mutant mice. Proc. Natl. Acad. Sci. USA. 92:1995;9137-9140.
8. Bayer S.A., Wills K.V., Triarhou L.C., Ghetti B. Time of neuron origin and gradients of neurogenesis in midbrain dopaminergic neurons in the mouse. Exp. Brain Res. 105:1995;191-199.
9. Broome J.D., Wills K.V., Lapchak P.A., Ghetti B., Camp L.L., Bayer S.A. Glial cell line-derived neurotrophic factor protects midbrain dopamine neurons from the lethal action of the weaver gene: a quantitative immunocytochemical study. Dev. Brain Res. 116:1999;1-7.
10. Burke R. Parkinson's disease. Koliatsos V.E., Ratan R.R., Cell Death and Diseases of the Nervous System. 1999;459-475 Human Press Inc. Totowa, NJ.
11. Choi-Lundberg D.L., Bohn M.C. Ontogeny and distribution of glial cell line-derived neurotrophic factor (GDNF) mRNA in rat. Dev. Brain Res. 85:1995;80-88.
12. Ghetti B., Triarhou L.C. Degeneration of mesencephalic dopamine neurons in weaver mutant nice. Neurochem. Int. 20:(Suppl.):1992;305S-307S.
13. Grondin R., Gash D.M. Glial cell line-derived neurotrophic factor (GDNF): a drug candidate for the treatment of Parkinson's disease. J. Neurol. 245:(Suppl. 3):1998;P35-P42.
14. Gupta M., Felten D.L., Ghetti B. Selective loss of monoaminergic neurons in weaver mutant mice-an immunocytochemical study. Brain Res. 402:1987;379-382.
15. Lapchak P.A., Gash D.M., Jiao S., Miller P.J., Hilt D. Glial cell line-derived neurotrophic factor: a novel therapeutic approach to treat motor dysfunction in Parkinson's disease. Exp. Neurol. 144:1997;29-34.
16. López-Martín E., Caruncho H.J., Rodríguez-Pallares J., Guerra M.J., Labandeira-Garcia J.L. Striatal dopaminergic afferents concentrate in GDNF-positive patches during development and in developing intrastiatal striatal grafts. J. Comp. Neurol. 406:1999;199-206.
17. J. Martí, K.V. Wills, B. Ghetti, S.A. Bayer, Lacking of weaver gene effect on mesencephalic late-generated dopaminergic neurons, Dev. Brain Res. 122 (2000) 165-172 (this issue).
18. Patil N., Cox D.R., Bhat D., Faham M., Myers R.M., Peterson A.S. A potassium channel mutation in weaver mice implicates membrane excitability in ganule differentiation. Nature Genet. 11:1995;126-129.
19. Roffler-Tarlov S., Martin B., Graybiel A.M., Kauer J.S. Cell death in the midbrain of the murine mutation weaver. J. Neurosci. 16:1996;1819-1826.
20. Schaar D.G., Sieber B.-A., Dreyfus C.F., Black I.B. Regional and cell-specific expression of GDNF in the rat brain. Exp. Neurol. 124:1993;368-371.
21. Schmidt M.J., Sawyer B.D., Perry K.W., Fuller R.W., Foreman M.M., Ghetti B. Dopamine deficiency in the weaver mutant mouse. J. Neurosci. 2:1982;376-380.
22. Smith M.W., Cooper T.R., Joh T.H., Smith D.E. Cell loss and class distribution of TH-I cells I in the substantia nigra of the neurological mutant, weaver. Brain Res. 510:1990;242-250.
23. Springer J.E., Mu X., Bergmann L.W., Trojanowski J.Q. Expression of GDNF mRNA in rat and human nervous tissue. Exp. Neurol. 127:1994;167-170.
24. Stromberg I., Bjorklund L., Johansson M., Tomac A., Collins F., Olson L., Hoffer B., Humpel C. Glial cell line-derived neurotrophic factor is expressed in the developing but not adult striatum and stimulates developing dopamine neurons in vivo. Exp. Neurol. 124:1993;401-412.
25. Triarhou L.C., Low W.C., Ghetti B. Transplantation of ventral mesencephalic anlage to hosts with genetic nigrostriatal dopamine deficiency. Proc. Natl. Acad. Sci. USA. 83:1986;8789-8793.
26. Triarhou L.C., Norton J., Ghetti B. Mesencephalic dopamine cell deficit involves areas A8, A9 and A10 in weaver mutant mice. Exp. Brain Res. 70:1988;256-265.
27. Triarhou L.C., Norton J., Ghetti B. Synaptic connectivity of tyrosine hydroxylase immunoreactive nerve terminals in the striatum of normal, heterozygous and homozygous weaver mutant mice. J. Neurocytol. 17:1988;221-232.
28. Verney C., Febvret-Muzerelle A., Gaspar P. Early postnatal changes of the dopaminergic mesencephalic neurons in the weaver mutant mouse. Dev. Brain Res. 89:1995;115-119.
29. Voorn P., Kalsbeek A., Jorritsma-Byham B., Groenewegen H.J. The pre and postnatal development of the dopaminergic cell groups in the ventral mesencephalon and the dopaminergic innervation of the striatum of the rat. Neuroscience. 25:1988;857-887.
30. Wei J., Hodes M.E., Piva R., Feng Y., Wang Y., Ghetti B., Dlouhy S.R. Characterization of murine Girk2 transcript isoforms: structure and differential expression. Genomics. 51:1998;379-390.